Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Califf

Showing results (561-570 of 565) with videos related to

Pageof 57
Sort By:
You have reached the last page of results.This site can display upto 565 results.
The New England Journal of Medicine|November 21, 2013
A pharmacogenetic versus a clinical algorithm for warfarin dosingStephen E Kimmel, Benjamin French, Scott E Kasner, et al.
JAMA Network Open|June 17, 2025
Modernizing Research and Evidence Consensus Definitions: A Food and Drug Administration-National Institutes of Health CollaborationDonna R Rivera, Tracy L Cutler, Lisa McShane, et al.
Journal of the American College of Cardiology|July 30, 2016
Reducing Health Inequities in the U.S.: Recommendations From the NHLBI's Health Inequities Think Tank MeetingUchechukwu K A Sampson, Robert M Kaplan, Richard S Cooper, et al.
The New England Journal of Medicine|March 16, 2010
Effect of valsartan on the incidence of diabetes and cardiovascular events, John J McMurray, Rury R Holman, et al.
The New England Journal of Medicine|March 16, 2010
Effect of nateglinide on the incidence of diabetes and cardiovascular events, Rury R Holman, Steven M Haffner, et al.
Pageof 57

Showing results (561-570 of 565) with videos related to

Sort By:
Pageof 57
You have reached the last page of results.This site can display upto 565 results.
The New England Journal of Medicine|November 21, 2013
A pharmacogenetic versus a clinical algorithm for warfarin dosingStephen E Kimmel, Benjamin French, Scott E Kasner, et al.
JAMA Network Open|June 17, 2025
Modernizing Research and Evidence Consensus Definitions: A Food and Drug Administration-National Institutes of Health CollaborationDonna R Rivera, Tracy L Cutler, Lisa McShane, et al.
Journal of the American College of Cardiology|July 30, 2016
Reducing Health Inequities in the U.S.: Recommendations From the NHLBI's Health Inequities Think Tank MeetingUchechukwu K A Sampson, Robert M Kaplan, Richard S Cooper, et al.
The New England Journal of Medicine|March 16, 2010
Effect of valsartan on the incidence of diabetes and cardiovascular events, John J McMurray, Rury R Holman, et al.
The New England Journal of Medicine|March 16, 2010
Effect of nateglinide on the incidence of diabetes and cardiovascular events, Rury R Holman, Steven M Haffner, et al.
Pageof 57